Dr. Xiaomin (Jasmine) Su
About Jasmine
Jasmine focuses her practice on strategic patent counseling and prosecution for clients in the biotechnology, pharmaceutical and medical device industries. She advises on global patent strategies and life cycle management, helping companies maximize intellectual property value from early-stage innovation through commercialization.
Jasmine brings deep technical experience and industry insight, particularly in cutting-edge areas such as antibody therapies, gene therapies, CAR-T cell therapies, CRISPR gene editing, RNA-based therapeutics, peptide therapies (including GLP-1), small molecule drugs, next-generation sequencing (NGS) diagnostics, and minimally invasive medical devices.
Before joining Cooley, Jasmine practiced at another leading DC law firm. She earned her PhD in immunology and microbiology from the University of Rochester, where her research focused on neurodegenerative diseases, and completed postdoctoral training at the University of California San Francisco, developing gene therapies for Parkinson’s disease.
Jasmine’s representative matters include:
- Metsera – Patent prosecution and IP diligence supporting its $275 million initial public offering and subsequent $10 billion acquisition by Pfizer
- Mammoth Biosciences – Patent prosecution and counseling for CRISPR-based therapeutics and diagnostics
- Aptevo Therapeutics – Patent prosecution and counseling for antibody and multi-specific antibody therapies
- Jazz Pharmaceuticals – Orange Book patent strategy and prosecution
- AtaiBeckley – Patent prosecution and counseling for clinical-stage psychedelic therapeutics
- Rocket Pharmaceuticals – Patent prosecution and counseling for lentiviral gene therapies
- Swiss Rocket – IP diligence for licensing deals with Complete Genomics (massively parallel sequencing (MPS)/NGS technology)
- Shenzhen MagicRNA – IP diligence for lipid nanoparticle (LNP) delivery of RNA therapies
- Windward Bio – IP diligence for licensing bispecific antibody technology
- Function Health – IP diligence for an acquisition related to blood testing technology
- Celgene – Patent prosecution and counseling for small molecule anti-cancer drugs*
- MicroSurgical Technology (MST) – Patent prosecution and counseling for eye surgery devices*
* Representation handled before joining Cooley
Admissions and credentials
- District of Columbia
- US Patent and Trademark Office (USPTO)
Education
-
American University Washington College of Law
JD, cum laude -
University of Rochester
PhD, Immunology -
University of Maryland, College Park
MS, Bioengineering -
South China University of Technology
BS, Bioengineering
Memberships and affiliations
- American Intellectual Property Law Association
- Asian Pacific American Bar Association